Physician profile
Dwayne North
NPI 1457745143
$530.22
in general payments reported to CMS, 2019-2025
10 companies · $23.78 in 2025
The $23.78 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $79.77 · 2022: $254 · 2024: $172 · 2025: $23.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $196.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endomagnetics LTD | $112.80 | 2022 | |
| Stryker Corporation | $108.08 | 2022 | |
| Ethicon US, LLC | $75.24 | 2021-2025 | Echelon Flex |
| Dilon Technologies, INC. | $49.57 | 2021 | |
| Kerecis Limited | $47.86 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Leica Microsystems INC. | $45.25 | 2024 | Hydromark Breast Biopsy Site Marker |
| Boston Scientific Corporation | $33.97 | 2024 | Spyglass Discover |
| Solventum Corporation | $28.47 | 2024 | V.A.C.Instill, Abthera Advance, Prevena |
| Smith+Nephew, INC. | $16.75 | 2024 | Collagenase Santyl |
| Abbvie INC. | $12.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dwayne North listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.